Accessibility Information

Users of assistive technologies such as screen readers should use the following link to activate Accessibility Mode before continuing: Learn more and Activate accessibility mode.

Video in Print Players

Solicitation Number: FDA-SOL-14-1130817
Agency: Department of Health and Human Services
Office: Food and Drug Administration
Location: Office of Acquisitions and Grants Services
  • Print
:
FDA-SOL-14-1130817
:
Sources Sought
:
Added: Mar 20, 2014 9:39 am
FDA Video in Print Sources Sought Notification

This Sources Sought/Request for Information (RFI) is being issued in accordance with Federal Acquisition Regulation Part 10, Market Research. It is for information, planning and market research purposes only and shall not be construed as either a solicitation or obligation on the part of the Food and Drug Administration (FDA) or its Centers. The purpose of this RFI is to help the FDA understand the industry best practices and technical solutions capable of providing the full range of requirements described in this RFI. FDA will use this market research information to assess the market's capability to successfully meet the FDA's video in print requirements.


Objective


The requirement described in this RFI is the design, production, and delivery to CTP of brochure style video cards uploaded with FDA supplied audio and video content that can be viewed by the end recipient. Quantity of approximately 3,000. Please refer to the attached draft Statement of Work.


Sources Sought


Another purpose of this Sources Sought Notice/RFI is to determine the availability and capability of qualified small businesses (including Small Business Administration Certified 8(a) companies; firms in Historically Underutilized Business Zones (HUBZone); Service-Disabled Veteran-Owned small businesses; and Women-Owned small businesses).


FDA welcomes responses from all interested parties.


Response Requirements


Responses to this notice shall be limited to ten pages (excluding marketing literature and/or technical data sheets) and must include:
1. Organization name, and telephone number and e-mail address of a point of contact having the authority and knowledge to clarify responses with Government representatives.
2. Name, title, telephone number and e-mail addresses of individuals who can verify the demonstrated technical capabilities identified in the responses, if different from the individual above.
3. Commercial pricing list(s) or other pricing information.
4. Customary practices, including warranties, discounts, and contract type(s) under which commercial sales of the products or services are made.
5. To ascertain if the system is commercially available, deployed and proven; a listing of other organizations (Government and/or private industry) that have implemented the interested party's item or service described in this notice.
6. Appropriate NAICS code.
7. DUNS number, CAGE code, and company structure (corporation, LLC, partnership, joint venture, etc.).
8. Verification of active registration in the System for Award Management (www.sam.gov).
9. Identification of any available contract vehicles, such as: GSA Federal Supply Schedules (schedule/contract number and appropriate Special Item Numbers) or other GWAC vehicles by agency and contract number.
10. Please provide the size classification of your business. If you are classified as a small business, HUBZone small business, Service Disabled Veteran Owned small business, Woman-owned small business and/or 8(a) certified small business, please provide a detailed capability statement, focusing on your firm's proven ability to provide the range of requirements. Additionally, please demonstrate your firm's capability to meet the requirements of FAR 52.219-14, Limitations on Subcontracting.
11. Any comments or suggestions concerning the FDA's requirements. Specifically:
a. Are any of the FDA's requirements too restrictive?
b. Are any of the FDA's requirements inconsistent with standard commercial practices?
c. Does your company have any suggestions the FDA may want to consider regarding this requirement?
12. Please include a description of how you would build your own players or repurpose another manufacturer's players (if applicable).
13. Please describe your company's production capacity and how your company can meet the 3,000 player requirement within the timeframes described throughout this notification. If the timeframes are inconsistent with standard commercial practices, please describe the timeframes more consistent with standard commercial practices.
14. Describe your company's environmental sustainability efforts and practices.
15. Describe how environmentally sustainable products and practices could be integrated in the FDA's requirement.


Acknowledgment of receipt of responses will not be made, nor will respondents be notified of the outcome of the FDA's review of the information received. Additionally, the FDA does not intend to hold discussions concerning this RFI with any interested parties. This request is not to be construed as a commitment on the part of the Government to award a contract, nor does the Government intend to pay for any information submitted as a result of this request. The Government will not reimburse respondents for any cost associated with submission of the information being requested or reimburse expenses incurred to interested parties for responses to this announcement. However, FDA reserves the right to contact one or more of the respondents if additional information is required or to request demonstrations.


Responses to this announcement will not be returned, nor will there be any ensuing discussions or debriefings of any responses. However, information obtained as a result of this announcement may be reflected in the subsequent solicitation if issued. This announcement is Government market research and may result in revisions in both its requirements and its acquisition strategy based on industry responses.


Any questions regarding this notice must be submitted in writing to Jacob.OHatnick@fda.hhs.gov.


Respondents must submit a capability statement addressing each of the requirements, tasks, and response requirements Jacob.OHatnick@fda.hhs.gov no later than the specified due date and time indicated on the Government Point of Entry (GPE) for consideration.


 

Please consult the list of document viewers if you cannot open a file.

Draft SOW

Type:
Other (Draft RFPs/RFIs, Responses to Questions, etc..)
Label:
Draft SOW
Posted Date:
March 20, 2014
Description: VIDEO IN PRINT PLAYERS draft SOW FY14
:
5630 Fishers Lane, Room 2129
Rockville, Maryland 20857-0001
:
Center for Tobacco Products
Food and Drug Administration
Rockville, Maryland 20850
United States
:
Jacob A. O'Hatnick
Phone: 3018276758